BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

908 related articles for article (PubMed ID: 24411336)

  • 21. A defined and xeno-free culture method enabling the establishment of clinical-grade human embryonic, induced pluripotent and adipose stem cells.
    Rajala K; Lindroos B; Hussein SM; Lappalainen RS; Pekkanen-Mattila M; Inzunza J; Rozell B; Miettinen S; Narkilahti S; Kerkelä E; Aalto-Setälä K; Otonkoski T; Suuronen R; Hovatta O; Skottman H
    PLoS One; 2010 Apr; 5(4):e10246. PubMed ID: 20419109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of N-glycolylneuraminic acid in human induced pluripotent stem cells generated or cultured under feeder- and serum-free defined conditions.
    Hayashi Y; Chan T; Warashina M; Fukuda M; Ariizumi T; Okabayashi K; Takayama N; Otsu M; Eto K; Furue MK; Michiue T; Ohnuma K; Nakauchi H; Asashima M
    PLoS One; 2010 Nov; 5(11):e14099. PubMed ID: 21124894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthetic mRNA Reprogramming of Human Fibroblast Cells.
    Liu J; Verma PJ
    Methods Mol Biol; 2015; 1330():17-28. PubMed ID: 26621585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Xeno-free culture of human pluripotent stem cells.
    Bergström R; Ström S; Holm F; Feki A; Hovatta O
    Methods Mol Biol; 2011; 767():125-36. PubMed ID: 21822871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of human induced pluripotent stem cells using genome integrating or non-integrating methods.
    Šimara P; Tesařová L; Padourová S; Koutná I
    Folia Biol (Praha); 2014; 60 Suppl 1():85-9. PubMed ID: 25369347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of a synthetic xeno-free culture substrate for induced pluripotent stem cell induction and retinal differentiation.
    Tucker BA; Anfinson KR; Mullins RF; Stone EM; Young MJ
    Stem Cells Transl Med; 2013 Jan; 2(1):16-24. PubMed ID: 23283489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GM-CSF and MEF-conditioned media support feeder-free reprogramming of mouse granulocytes to iPS cells.
    Firas J; Liu X; Nefzger CM; Polo JM
    Differentiation; 2014 Jun; 87(5):193-9. PubMed ID: 25015842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Derivation of GMP-compliant integration-free hiPSCs using modified mRNAs.
    Durruthy JD; Sebastiano V
    Methods Mol Biol; 2015; 1283():31-42. PubMed ID: 25304205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expansion and long-term maintenance of induced pluripotent stem cells in stirred suspension bioreactors.
    Shafa M; Sjonnesen K; Yamashita A; Liu S; Michalak M; Kallos MS; Rancourt DE
    J Tissue Eng Regen Med; 2012 Jun; 6(6):462-72. PubMed ID: 21761573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Robust production of human neural cells by establishing neuroepithelial-like stem cells from peripheral blood mononuclear cell-derived feeder-free iPSCs under xeno-free conditions.
    Isoda M; Kohyama J; Iwanami A; Sanosaka T; Sugai K; Yamaguchi R; Matsumoto T; Nakamura M; Okano H
    Neurosci Res; 2016 Sep; 110():18-28. PubMed ID: 27083781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of Induced Pluripotent Stem Cells (iPSCs) from Adult Canine Fibroblasts.
    Koh S; Piedrahita JA
    Methods Mol Biol; 2015; 1330():69-78. PubMed ID: 26621590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
    Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
    Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of pluripotent stem cells by reprogramming human ocular fibroblasts under xeno-free conditions.
    Xiong Y; Liu Y; Ge J
    Arq Bras Oftalmol; 2018; 81(5):376-383. PubMed ID: 30208139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defined human pluripotent stem cell culture enables highly efficient neuroepithelium derivation without small molecule inhibitors.
    Lippmann ES; Estevez-Silva MC; Ashton RS
    Stem Cells; 2014 Apr; 32(4):1032-42. PubMed ID: 24357014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors.
    Ramos-Mejía V; Montes R; Bueno C; Ayllón V; Real PJ; Rodríguez R; Menendez P
    PLoS One; 2012; 7(4):e35824. PubMed ID: 22545141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of Human Induced Pluripotent Stem Cells Using a Defined, Feeder-Free Reprogramming System.
    Park S; Mostoslavsky G
    Curr Protoc Stem Cell Biol; 2018 May; 45(1):e48. PubMed ID: 30040234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation and Neuronal Differentiation of Patient-Specific Induced Pluripotent Stem Cells Derived from Niemann-Pick Type C1 Fibroblasts.
    Trilck M; Hübner R; Frech MJ
    Methods Mol Biol; 2016; 1353():233-59. PubMed ID: 25520288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term serial cultivation of mouse induced pluripotent stem cells in serum-free and feeder-free defined medium.
    Yamasaki S; Nabeshima K; Sotomaru Y; Taguchi Y; Mukasa H; Furue MK; Sato JD; Okamoto T
    Int J Dev Biol; 2013; 57(9-10):715-24. PubMed ID: 24307297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and evaluation of a novel xeno-free culture medium for human-induced pluripotent stem cells.
    Hua Y; Yoshimochi K; Li J; Takekita K; Shimotsuma M; Li L; Qu X; Zhang J; Sawa Y; Liu L; Miyagawa S
    Stem Cell Res Ther; 2022 Jun; 13(1):223. PubMed ID: 35658933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic effect of medium, matrix, and exogenous factors on the adhesion and growth of human pluripotent stem cells under defined, xeno-free conditions.
    Meng G; Liu S; Rancourt DE
    Stem Cells Dev; 2012 Jul; 21(11):2036-48. PubMed ID: 22149941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.